Showing 1871-1880 of 3597 results for "".
Psoriasis Treatment in 2025: More Options, Better Outcomes
https://practicaldermatology.com/issues/august-2025/psoriasis-treatment-in-2025-more-options-better-outcomes/36706/We have better drugs to treat psoriasis than almost any other dermatologic disease state. For patients, it is an excellent time to have psoriasis.GLP-1 Receptor Agonists: Current Roles in Medicine
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-current-roles-in-medicine/48897/In recent years, the popularity of glucagon-like peptide 1 receptor agonists (GLP-1RAs) has skyrocketed, along with interest in clinical applications beyond diabetes and weight management. Here, we present a brief review of GLP-1RAs, including a history, a look at the mechanism of action, pivotal reNew Products/New In My Practice: OTC
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-productsnew-in-my-practice-otc-4/23135/Biologics in Psoriasis: The Next Generation
https://practicaldermatology.com/topics/psoriasis/biologics-in-psoriasis-the-next-generation/20807/Get familiar with the IL-23 monoclonal antibodies.2024 In Review: This Year's Trends in Dermatology
https://practicaldermatology.com/topics/feature/2024-review-years-trends-dermatology/29886/As the year comes to a close, Practical Dermatology asked Editorial Board members about trends from 2024—what was hot, what was not, new approvals that lived up to the hype, important new research, and other observations from the past year.The Colemans: Dermatology as a Father-Son(s) Tradition
https://practicaldermatology.com/topics/feature/colemans-dermatology-father-sons-tradition/26956/The Colemans: Dermatology as a Father-Son(s) TraditionHow Will Dermatologists Use ChatGPT?
https://practicaldermatology.com/topics/practice-management/how-will-dermatologists-use-chatgpt/23876/Dr. Patel explores the potential role of ChatGPT in clinical practice and academics.Clascoterone: A Novel Topical Anti-androgen for the Treatment of Acne
https://practicaldermatology.com/columns/clinical-focus-1/clascoterone-a-novel-topical-anti-androgen-for-the-treatment-of-acne/23133/For the first time in almost 15 years, a new chemical entity may be coming to the market for the topical treatment of acne vulgaris.AbbVie's Skyrizi Approved, Brooke Shields Endorses SculpSure
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-abbvies-skyrizi-approved-brooke-shi/19607/Skyrizi, an interleukin-23 inhibitor from AbbVie, is FDA approved for the treatment of moderate to severe plaque psoriasis in adults. Brooke Shields is the face of the new “Be strong. Be sexy. Be confident” campaign for SculpSure, from Hologic’s Cynosure. The Noah Worcester Dermatological Society anSuccessful Meetings: It's All About the Follow-up
https://practicaldermatology.com/topics/practice-management/successful-meetings-its-all-about-the-follow-up/20456/Frustrated by meetings that are run well but produce limited results? Then try keeping an eye on what happens afterwards.